Reprogramming translation for gene therapy.

Area of Science:

• Molecular Biology
• Gene Expression Regulation
• Biotechnology

Background:

• Translational control is crucial for eukaryotic gene expression, enabling fine-tuning of protein levels and cellular responses.
• Mechanisms of translational regulation include initiation, elongation, and termination, with cis-acting elements in the 5' UTR significantly impacting initiation.
• Key cis-elements like Kozak sequences, upstream open reading frames (uORFs), and internal ribosomal entry sites (IRESs) influence translation initiation.

Purpose of the Study:

• To investigate genome editing approaches for modulating translational efficiency.
• To explore therapeutic applications by targeting cis-elements that regulate protein synthesis initiation.
• To leverage CRISPR-Cas technology for precise control over gene expression at the translational level.

Main Methods:

• Focus on CRISPR-Cas genome editing techniques.
• Analysis of cis-acting elements within the 5' untranslated region (UTR) of transcripts.
• Strategies targeting translational initiation mechanisms.

Main Results:

• Demonstration of CRISPR-Cas technology's applicability in regulating gene expression.
• Identification of specific cis-elements (Kozak, uORFs, IRESs) as targets for translational control.
• Potential for developing novel therapeutic strategies based on translational modulation.

Conclusions:

• CRISPR-Cas based genome editing offers a powerful tool to modulate translational efficiency.
• Targeting cis-regulatory elements involved in translation initiation presents promising therapeutic avenues.
• This approach holds potential for fine-tuning gene expression for various applications.